Journal ArticleUnknown
Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium
Authors
Author Affiliations
KU Leuven, Rega Institute for Medical Research, International Centre for Diarrhoeal Disease Research
Published InVaccine
Year2010
Citations221
Abstract
Rotarix™ was introduced into the Belgian market in 2006 and RotaTeq™ in 2007, quickly reaching more than 85% vaccine coverage of all newborns in Belgium. The incidence of rotavirus gastroenteritis has been monitored in the Gasthuisberg University Hospital (GUH), Belgium since 1986, and since 1999 the genotypes of circulating rotavirus strains have been determined. The average percentage of rotavirus positive cases out of all hospitalized gastro-enteritis cases tested (>95% of these cases are younger than 5 years old) at the GUH between 1986 and 2006 was 19.0%. This percentage dropped to 12.4%, 9.6% and 6.4% in the three seasons post vaccine introduction (2006-2009), which is a decline of 34.7%, 49.4% and 66.3% respectively. In addition the rotavirus season was found…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.